Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|18|3212-3220

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.18, 2015-09, pp. : 3212-3220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract